{
  "actions": [
    {
      "acted_at": "2018-09-13",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2018-09-13",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr6801-115",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "115",
  "cosponsors": [
    {
      "bioguide_id": "P000608",
      "district": "52",
      "name": "Peters, Scott H.",
      "original_cosponsor": true,
      "sponsored_at": "2018-09-13",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "R000583",
      "district": "17",
      "name": "Rooney, Thomas J.",
      "original_cosponsor": true,
      "sponsored_at": "2018-09-13",
      "state": "FL",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2018-09-13",
  "number": "6801",
  "official_title": "To establish a Rare Disease Therapeutics Corporation to encourage the development of high-risk, high-return therapies for rare diseases, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "RaD Fund Act of 2018",
  "sponsor": {
    "bioguide_id": "V000130",
    "district": "51",
    "name": "Vargas, Juan",
    "state": "CA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2018-09-13",
  "subjects": [
    "Advisory bodies",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Drug therapy",
    "Health",
    "Health programs administration and funding",
    "Health technology, devices, supplies",
    "Medical research",
    "National Institutes of Health (NIH)",
    "Research administration and funding",
    "Research and development"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2018-09-13",
    "date": "2019-08-20T20:32:00Z",
    "text": "Rare Disease Fund Act of 2018 or the RaD Fund Act of 2018\n\nThis bill requires the Department of the Treasury to organize the Rare Disease Therapeutics Corporation to purchase rights to, fund the development of, and sell ownership interests in drugs, biological products, and medical devices for rare diseases."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "RaD Fund Act of 2018",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To establish a Rare Disease Therapeutics Corporation to encourage the development of high-risk, high-return therapies for rare diseases, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "RaD Fund Act of 2018",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Rare Disease Fund Act of 2018",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:41:33Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/hr/BILLSTATUS-115hr6801.xml"
}